The blood based biomarker market is estimated to be valued at US$ 18.8 billion in 2022 and is expected to exhibit a CAGR of 12.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Blood based biomarkers are biological molecules found in blood that are indicators of normal or abnormal processes, or of conditions or diseases...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian